Acura Pharmaceuticals Net Change in Investments - Total 2010-2021 | ACUR

Acura Pharmaceuticals net change in investments - total from 2010 to 2021. Net change in investments - total can be defined as the total change in long term and short term investments
Acura Pharmaceuticals Annual Net Change in Investments - Total
(Millions of US $)
2021 $N/A
2020 $N/A
2019 $N/A
2018 $N/A
2017 $N/A
2016 $11
2015 $0
2014 $2
2013 $6
2012 $-20
2011 $N/A
2010 $N/A
2009 $5
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.001B $0.000B
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.298B 6.98
Dr Reddy's Laboratories (RDY) India $12.071B 21.91
BridgeBio Pharma (BBIO) United States $6.397B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.850B 15.02
Bausch Health Cos (BHC) Canada $1.681B 1.24
Amphastar Pharmaceuticals (AMPH) United States $1.178B 7.84
Taysha Gene Therapies (TSHA) United States $0.599B 0.00
Personalis (PSNL) United States $0.443B 0.00
Assembly Biosciences (ASMB) United States $0.105B 0.00
Sol-Gel Technologies (SLGL) Israel $0.021B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00